Development of Non-Infringement Patent-safe Cartridges

Development of Non-Infringement Patent-safe Cartridges

Development of Non-Infringement Patent-safe Cartridges

Development of Non-Infringement Patent-safe CartridgesHaoYinBao Group (HYB)  claims to not only be an empty cartridge remanufacturer for copiers, but also a pioneer in the development of patent-safe cartridges.

The company has revealed more than 480 self-developed patent-safe cartridge SKUs are available for customers looking for non-infringing products. The product range suits dealers and manufacturers seeking quality, compatible Ricoh, Canon, Xerox, Konica Minolta products.

HYB claims its professional R&D team for copier cartridges is rich with experience in the engineering and structural characteristics of different copier machines. Its dedicated laboratories for copiers allow its technical department to test their innovations on site and to continue improving the design until the products work seamlessly as replacements to the OEM products.

In addition to the 480 SKUs, HYB claims other new patent-safe cartridges will be launched to the market in 2021. “HYB will never stop its constant innovation in new product development so as to provide IP-safe products for our customers,” said an HYB spokesperson.

Previously, HYB released two new fuser unit solutions for HP and Xerox printers.

According to HYB, the remanufactured fuser unit HYB-FA-LjP4010 is for use in HP Lj P4014/4015/P4515, replacing O.E.M Part #PN RM1-4579 and CB506-67902. The other new release, namely HYB-FA-WC7525, is for use in XEROX Workcentre 7525/7530/7535/7545/7556/7830/7835/7845/7855, which replaces O.E.M Part #PN 604K94280/604k62210.


Contact Details:

Address:No.6, Ping Xishi Rd, Nanping Industrial Park, Zhuhai City, China.
Tel: +86–756-857-8633Whats App:+86 139 2690-6062
E-mail:kim@haoyinbao.com (pictured)

Website:  www.copiertonerpro.com

Social Media:


Related:

Comment:

Please leave your comments on the story “Development of Non-Infringement Patent-safe Cartridges” below.

0 replies

Leave a Comment

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *